Wong T Y, Szeto C C, Chow K M, Chan J C, Li P K
Department of Medicine and Therapeutics, The Chinese University of Hong Kong, The Prince of Wales Hospital, Shatin, Hong Kong, China.
Am J Kidney Dis. 2001 Jul;38(1):9-17. doi: 10.1053/ajkd.2001.25175.
The renin-angiotensin system is important in the control of hemodynamic status and pathogenesis of macrovascular disease, which is a major cause of morbidity and mortality in patients with type 2 diabetes with nephropathy. Serum angiotensin-converting enzyme (ACE) and angiotensinogen (Atg) levels are related to their respective gene polymorphisms. Seventy patients with type 2 diabetes with overt nephropathy (serum creatinine >/= 1.5 mg/dL) were studied. Serum ACE activity was measured by the spectrophotometric method. ACE deletion/insertion (D/I) and Atg M235T genotypes were determined by polymerase chain reaction. Patients with and without macroangiopathy were compared. Those with macroangiopathy had increased ACE activity (median, 60.9 U/L; range, 37.9 to 100 U/L versus without macroangiopathy, 47.9 U/L; range, 11.2 to 84.5 U/L; P = 0.01) and prevalence of ACE DD/DI genotypes (DD/DI:II: with macroangiopathy, 61%:39% versus without macroangiopathy, 34%:66%; P = 0.03). Multivariate analysis using age; sex; duration of diabetes; glycemic, blood pressure, and lipid level control; serum creatinine level; and presence of the ACE D allele showed that presence of the D allele (P = 0.03; odds ratio, 1.8; confidence interval, 1.1 to 3.1) and serum creatinine level (P = 0.0007) were independent risk factors for macroangiopathy. Association of the D allele became insignificant after serum ACE activity was included in the analysis in which only serum ACE activity (P = 0.004) and serum creatinine level (P = 0.01) were independent risk factors. Neither Atg M235T nor its synergistic effect with the ACE D allele showed an association with macroangiopathy. In conclusion, the ACE D allele is associated with macroangiopathy in Chinese patients with type 2 diabetes with nephropathy. The association is dependent on its effect on serum ACE activity, which is an independent risk factor for the development of macroangiopathy.
肾素 - 血管紧张素系统在血流动力学状态的控制及大血管疾病的发病机制中起重要作用,而大血管疾病是2型糖尿病肾病患者发病和死亡的主要原因。血清血管紧张素转换酶(ACE)和血管紧张素原(Atg)水平与其各自的基因多态性相关。对70例2型糖尿病显性肾病患者(血清肌酐≥1.5mg/dL)进行了研究。采用分光光度法测定血清ACE活性。通过聚合酶链反应确定ACE缺失/插入(D/I)和Atg M235T基因型。比较了有和无大血管病变的患者。有大血管病变的患者ACE活性增加(中位数,60.9U/L;范围,37.9至100U/L,无大血管病变者为47.9U/L;范围,11.2至84.5U/L;P = 0.01),且ACE DD/DI基因型的患病率较高(DD/DI:II:有大血管病变者为61%:39%,无大血管病变者为34%:66%;P = 0.03)。使用年龄、性别、糖尿病病程、血糖、血压和血脂水平控制、血清肌酐水平以及ACE D等位基因的存在进行多变量分析显示,D等位基因的存在(P = 0.03;比值比,1.8;置信区间,1.1至3.1)和血清肌酐水平(P = 0.0007)是大血管病变的独立危险因素。在分析中纳入血清ACE活性后,D等位基因的关联性变得不显著,此时只有血清ACE活性(P = 0.004)和血清肌酐水平(P = 0.01)是独立危险因素。Atg M235T及其与ACE D等位基因的协同作用均未显示与大血管病变有关联。总之,在中国2型糖尿病肾病患者中,ACE D等位基因与大血管病变相关。这种关联取决于其对血清ACE活性的影响,而血清ACE活性是大血管病变发生的独立危险因素。